With increasing variants identified, the phenotypic spectrums of KCNN3 and KCNH1 are expanding, from syndromic neurodevelopmental disorder to pure epilepsy (Leu et al., 2020; Gripp et al., 2021). This evidence concerns the gene KCNH1 and neurodevelopmental disorder.